Abpro Corp
Monoclonal antibody therapeutics for severe and life-threatening diseases
- Sector
- Biotech
- Headquarters
- WOBURN, MA
- Latest Form D
- $2M, Apr 2022
- Total capital
- $42.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $42.4M
- 4 Form D · last Apr 2022
- 55 months since last filing
- Federal contracts
- $66K
- 7 awards · Health and Human S, Agriculture, Veterans Affairs
- Rank in Biotech#346 of 4373
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$2M
- Private capital raisedForm D · SEC · 3rd filing$18M
- Private capital raisedForm D · SEC · 2nd filing$10M
- Federal contractDefense · Igf::ot::igf Service For Immunomax Tm Monoclonal Antibody$12K
- Private capital raisedForm D · SEC · 1st filing$12.4M
- Federal contractHealth and Human S · Igf::ot::igf Other Functions -custome Monoclonal Antibody Production$10K
- Federal contractVeterans Affairs · Igf::ot::igf Hybridoma Subclones$9K
Show 4 earlier federal awards
- Federal contractHealth and Human S · Igf::ot::igf For Other Functions Subcoloning And Isotyping Services Abpro$3K
- Federal contractHealth and Human S · Custom Mouse Monoclonal Antibody$6K
- Federal contractAgriculture · Igf::cl::igf // Attn Lara HICOK//13LJH959//HTP$11K
- Federal contractHealth and Human S · Phase I Immunization - 3 Female Htp Mice (ambis #1599231)$14K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
42months
from Abpro Corp’s first federal award to its first private round.
- First federal award · Sep 2012
- Health and Human S · $14K
- First Form D · Mar 2016
- $12.4M · 1st Form D
- Awards before first raise
- 6 awards
An association in public records, not a cause or a prediction.
Founders and team
From SEC Form D filings- Adam S. MostafaExecutive OfficerNamed in SEC Form D filings
- Benjamin HaDirectorNamed in SEC Form D filings
- Eugene ChanDirectorNamed in SEC Form D filings
- Feng S. YeDirectorNamed in SEC Form D filings
- Ian ChanExecutive Officer, DirectorNamed in SEC Form D filings
- Kevin ComerfordExecutive OfficerNamed in SEC Form D filings
Show all 11 people
- Mark J. TangDirectorNamed in SEC Form D filings
- Miles J. SukDirectorNamed in SEC Form D filings
- Robert J. LangerDirectorNamed in SEC Form D filings
- Shengxin QinDirectorNamed in SEC Form D filings
- Thomas WengDirectorNamed in SEC Form D filings
What it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- BIOLYTIC LAB PERFORMANCE, INC.Similar federal contract value in Biotech · $72K in contracts
- ARDELYX, INC.Similar federal contract value in Biotech · $72K in contracts
- ATELERIX LIFE SCIENCES INCSimilar federal contract value in Biotech · $68K in contracts
- RETROTHERAPY, LLCSimilar federal contract value in Biotech · $65K in contracts
- CELLULAR RESEARCH, INC.Similar federal contract value in Biotech · $63K in contracts
- Radiant Genomics, Inc.Similar federal contract value in Biotech · $63K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .